产品编号:C371385
产品规格:250mg
产品价格:面议
| 标准品编号: | C371385 |
| 名称: | 1-{[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine Dihydrochloride |
| 别名: | 1-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-piperazine Hydrochloride (1:2); 1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine Dihydrochloride; |
| CAS号: | 1628047-87-9 |
| 参考CAS: | Free Base: 1228780-72-0 |
| 分子式: | C₁₉H₂₇ClN₂•(HCl)₂ |
| 分子量: | 318.8836462 |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | 1-{[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine Dihydrochloride is an intermediate used in the preparation of Venetoclax (A112430), which is a potent and selective BCL-2 inhibitor with potent antitumour activity while sparing platelets. Venetoclax is used to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer. |
| 参考文献 | |